4P Dermatology: A Shift to a Comprehensive Patient‐Centered Model Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/jvc2.70090
Advances in dermatology are embracing a patient‐centered, proactive approach through the ‘4P model’: Personalized, Predictive, Preventive, and Participatory care. This shift aims to improve treatment efficacy and safety as well as patient's quality of life. This review explores the applications of ‘4P medicine’ in dermatology, highlighting key concepts and examples like innovations in onco‐dermatology and the skin microbiome. In onco‐dermatology, molecular profiling guides targeted treatments, while genetic insights improve risk prediction and prevention. Genetic profiling, such as the identification of BRAF mutations in melanoma, has enabled targeted therapies like BRAF/MEK inhibitors to improve patient outcomes. Predictive technologies, including machine learning, are enabling early detection and risk assessment for both melanoma and non‐melanoma skin cancers. Preventive strategies focus on proactive skin care, with public education campaigns and digital tools to increase sun protection behaviors and early detection. Participatory care engages patients in decision making, leading to better adherence and outcomes. This integrated approach optimizes outcomes and reduces the burden of skin cancer. Microbiome research has also transformed dermatology, enabling personalized treatments that target microbial imbalances in conditions such as atopic dermatitis, psoriasis and acne. Predictive dermatology uses microbiome signatures to forecast disease risk and response to treatment, enabling earlier intervention. Preventive strategies aim to maintain a healthy microbiome and prevent disease exacerbations. Participatory dermatology encourages patients to engage in microbiome‐focused skin care to optimize outcomes. However, challenges remain in terms of treatment optimization, economic sustainability, ethical considerations and equitable access to care. Addressing these challenges requires innovative solutions, collaborative research, and strategies to ensure the accessibility and cost‐effectiveness of dermatologic care.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/jvc2.70090
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jvc2.70090
- OA Status
- gold
- Cited By
- 1
- References
- 99
- OpenAlex ID
- https://openalex.org/W4414267109
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414267109Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/jvc2.70090Digital Object Identifier
- Title
-
4P Dermatology: A Shift to a Comprehensive Patient‐Centered ModelWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-01Full publication date if available
- Authors
-
Brigitte Dréno, Cristián Navarrete‐Dechent, Jorge Ocampo‐Candiani, Thierry Passeron, Ketty PerisList of authors in order
- Landing page
-
https://doi.org/10.1002/jvc2.70090Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jvc2.70090Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jvc2.70090Direct OA link when available
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
99Number of works referenced by this work
Full payload
| id | https://openalex.org/W4414267109 |
|---|---|
| doi | https://doi.org/10.1002/jvc2.70090 |
| ids.doi | https://doi.org/10.1002/jvc2.70090 |
| ids.openalex | https://openalex.org/W4414267109 |
| fwci | 3.27053909 |
| type | article |
| title | 4P Dermatology: A Shift to a Comprehensive Patient‐Centered Model |
| biblio.issue | S1 |
| biblio.volume | 4 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10392 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9876999855041504 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cutaneous Melanoma Detection and Management |
| topics[1].id | https://openalex.org/T13597 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9847999811172485 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2708 |
| topics[1].subfield.display_name | Dermatology |
| topics[1].display_name | Medicine and Dermatology Studies History |
| topics[2].id | https://openalex.org/T11730 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9842000007629395 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2734 |
| topics[2].subfield.display_name | Pathology and Forensic Medicine |
| topics[2].display_name | Autoimmune Bullous Skin Diseases |
| is_xpac | False |
| apc_list.value | 2200 |
| apc_list.currency | USD |
| apc_list.value_usd | 2200 |
| apc_paid.value | 2200 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2200 |
| language | en |
| locations[0].id | doi:10.1002/jvc2.70090 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210221814 |
| locations[0].source.issn | 2768-6566 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2768-6566 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | JEADV Clinical Practice |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jvc2.70090 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | JEADV Clinical Practice |
| locations[0].landing_page_url | https://doi.org/10.1002/jvc2.70090 |
| locations[1].id | pmh:oai:doaj.org/article:8d584342dc0948f5b6b1ac7912392f7d |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | JEADV Clinical Practice, Vol 4, Iss S1, Pp S15-S25 (2025) |
| locations[1].landing_page_url | https://doaj.org/article/8d584342dc0948f5b6b1ac7912392f7d |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5002644565 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5574-5825 |
| authorships[0].author.display_name | Brigitte Dréno |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I97188460 |
| authorships[0].affiliations[0].raw_affiliation_string | Nantes University Nantes France |
| authorships[0].institutions[0].id | https://openalex.org/I97188460 |
| authorships[0].institutions[0].ror | https://ror.org/03gnr7b55 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I97188460 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Nantes Université |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Brigitte Dréno |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Nantes University Nantes France |
| authorships[1].author.id | https://openalex.org/A5062898613 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4040-3640 |
| authorships[1].author.display_name | Cristián Navarrete‐Dechent |
| authorships[1].countries | CL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I162148367 |
| authorships[1].affiliations[0].raw_affiliation_string | Pontificia Universidad Catolica de Chile Santiago Chile |
| authorships[1].institutions[0].id | https://openalex.org/I162148367 |
| authorships[1].institutions[0].ror | https://ror.org/04teye511 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I162148367 |
| authorships[1].institutions[0].country_code | CL |
| authorships[1].institutions[0].display_name | Pontificia Universidad Católica de Chile |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Cristian Navarrete‐Dechent |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Pontificia Universidad Catolica de Chile Santiago Chile |
| authorships[2].author.id | https://openalex.org/A5090926923 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-0213-0031 |
| authorships[2].author.display_name | Jorge Ocampo‐Candiani |
| authorships[2].countries | MX |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I169046204 |
| authorships[2].affiliations[0].raw_affiliation_string | Departamento de Dermatología Facultad de Medicina y Hospital Universitario, Universidad Autónoma de Nuevo León‐Monterrey San Nicolás de los Garza México |
| authorships[2].institutions[0].id | https://openalex.org/I169046204 |
| authorships[2].institutions[0].ror | https://ror.org/01fh86n78 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I169046204 |
| authorships[2].institutions[0].country_code | MX |
| authorships[2].institutions[0].display_name | Universidad Autónoma de Nuevo León |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jorge Ocampo‐Candiani |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Departamento de Dermatología Facultad de Medicina y Hospital Universitario, Universidad Autónoma de Nuevo León‐Monterrey San Nicolás de los Garza México |
| authorships[3].author.id | https://openalex.org/A5034396531 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0797-6570 |
| authorships[3].author.display_name | Thierry Passeron |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I3018988418 |
| authorships[3].affiliations[0].raw_affiliation_string | CHU Nice Nice France |
| authorships[3].institutions[0].id | https://openalex.org/I3018988418 |
| authorships[3].institutions[0].ror | https://ror.org/05qsjq305 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I3018988418 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Centre Hospitalier Universitaire de Nice |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Thierry Passeron |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | CHU Nice Nice France |
| authorships[4].author.id | https://openalex.org/A5102799702 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1957-6600 |
| authorships[4].author.display_name | Ketty Peris |
| authorships[4].countries | IT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I103320735 |
| authorships[4].affiliations[0].raw_affiliation_string | Catholic University Rome Italy |
| authorships[4].institutions[0].id | https://openalex.org/I103320735 |
| authorships[4].institutions[0].ror | https://ror.org/03h7r5v07 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I103320735 |
| authorships[4].institutions[0].country_code | IT |
| authorships[4].institutions[0].display_name | Università Cattolica del Sacro Cuore |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Ketty Peris |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Catholic University Rome Italy |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jvc2.70090 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 4P Dermatology: A Shift to a Comprehensive Patient‐Centered Model |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10392 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9876999855041504 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cutaneous Melanoma Detection and Management |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1002/jvc2.70090 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210221814 |
| best_oa_location.source.issn | 2768-6566 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2768-6566 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | JEADV Clinical Practice |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jvc2.70090 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | JEADV Clinical Practice |
| best_oa_location.landing_page_url | https://doi.org/10.1002/jvc2.70090 |
| primary_location.id | doi:10.1002/jvc2.70090 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210221814 |
| primary_location.source.issn | 2768-6566 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2768-6566 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | JEADV Clinical Practice |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jvc2.70090 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | JEADV Clinical Practice |
| primary_location.landing_page_url | https://doi.org/10.1002/jvc2.70090 |
| publication_date | 2025-09-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4281382713, https://openalex.org/W2017602032, https://openalex.org/W2695787953, https://openalex.org/W4385655267, https://openalex.org/W4404195837, https://openalex.org/W3182029025, https://openalex.org/W3015372198, https://openalex.org/W1515922954, https://openalex.org/W2558968931, https://openalex.org/W4401125285, https://openalex.org/W2523439769, https://openalex.org/W3082723162, https://openalex.org/W2972268072, https://openalex.org/W3216892619, https://openalex.org/W4213441875, https://openalex.org/W4308257224, https://openalex.org/W3178662265, https://openalex.org/W3023194989, https://openalex.org/W4290779664, https://openalex.org/W2895515487, https://openalex.org/W2268626500, https://openalex.org/W4406846160, https://openalex.org/W3011713286, https://openalex.org/W2970328881, https://openalex.org/W4404727451, https://openalex.org/W1552798134, https://openalex.org/W2161347545, https://openalex.org/W2586198214, https://openalex.org/W4391607628, https://openalex.org/W4391513355, https://openalex.org/W4402485282, https://openalex.org/W4400083113, https://openalex.org/W4403870792, https://openalex.org/W4392978836, https://openalex.org/W2965553652, https://openalex.org/W2767217931, https://openalex.org/W4283369626, https://openalex.org/W2979592680, https://openalex.org/W4205548565, https://openalex.org/W2781481943, https://openalex.org/W4385969629, https://openalex.org/W4388333539, https://openalex.org/W4206545240, https://openalex.org/W4254299740, https://openalex.org/W4396861225, https://openalex.org/W4394797882, https://openalex.org/W3136079049, https://openalex.org/W4200011819, https://openalex.org/W3172779859, https://openalex.org/W4283365697, https://openalex.org/W3126249119, https://openalex.org/W3036983089, https://openalex.org/W4404117929, https://openalex.org/W4400059954, https://openalex.org/W4378348526, https://openalex.org/W4406349231, https://openalex.org/W4402515199, https://openalex.org/W4307772787, https://openalex.org/W4306410908, https://openalex.org/W2572224374, https://openalex.org/W4381046874, https://openalex.org/W4406199500, https://openalex.org/W2727371760, https://openalex.org/W4400853536, https://openalex.org/W4367048139, https://openalex.org/W3083151730, https://openalex.org/W4387189731, https://openalex.org/W4390447135, https://openalex.org/W4402370348, https://openalex.org/W3165377617, https://openalex.org/W2605718316, https://openalex.org/W4400729394, https://openalex.org/W2891224051, https://openalex.org/W4294917547, https://openalex.org/W4386467668, https://openalex.org/W4392153612, https://openalex.org/W3038739807, https://openalex.org/W3143877554, https://openalex.org/W2019993336, https://openalex.org/W2258535515, https://openalex.org/W2986313081, https://openalex.org/W4392351729, https://openalex.org/W4225248818, https://openalex.org/W2569993564, https://openalex.org/W2893715656, https://openalex.org/W3187467406, https://openalex.org/W2768775511, https://openalex.org/W4382933583, https://openalex.org/W3206722128, https://openalex.org/W2886283492, https://openalex.org/W4403299793, https://openalex.org/W2982669867, https://openalex.org/W4317615864, https://openalex.org/W2346401928, https://openalex.org/W4393251330, https://openalex.org/W4362601563, https://openalex.org/W4394767334, https://openalex.org/W4404529281, https://openalex.org/W4284704564 |
| referenced_works_count | 99 |
| abstract_inverted_index.a | 6, 205 |
| abstract_inverted_index.In | 59 |
| abstract_inverted_index.as | 29, 31, 77, 178 |
| abstract_inverted_index.in | 2, 44, 53, 83, 141, 175, 218, 228 |
| abstract_inverted_index.of | 34, 41, 80, 159, 230, 258 |
| abstract_inverted_index.on | 118 |
| abstract_inverted_index.to | 23, 92, 129, 145, 189, 195, 203, 216, 222, 240, 252 |
| abstract_inverted_index.aim | 202 |
| abstract_inverted_index.and | 17, 27, 49, 55, 72, 105, 111, 126, 134, 148, 155, 182, 193, 208, 237, 250, 256 |
| abstract_inverted_index.are | 4, 101 |
| abstract_inverted_index.for | 108 |
| abstract_inverted_index.has | 85, 164 |
| abstract_inverted_index.key | 47 |
| abstract_inverted_index.sun | 131 |
| abstract_inverted_index.the | 11, 39, 56, 78, 157, 254 |
| abstract_inverted_index.BRAF | 81 |
| abstract_inverted_index.This | 20, 36, 150 |
| abstract_inverted_index.aims | 22 |
| abstract_inverted_index.also | 165 |
| abstract_inverted_index.both | 109 |
| abstract_inverted_index.care | 138, 221 |
| abstract_inverted_index.like | 51, 89 |
| abstract_inverted_index.risk | 70, 106, 192 |
| abstract_inverted_index.skin | 57, 113, 120, 160, 220 |
| abstract_inverted_index.such | 76, 177 |
| abstract_inverted_index.that | 171 |
| abstract_inverted_index.uses | 186 |
| abstract_inverted_index.well | 30 |
| abstract_inverted_index.with | 122 |
| abstract_inverted_index.acne. | 183 |
| abstract_inverted_index.care, | 121 |
| abstract_inverted_index.care. | 19, 241, 260 |
| abstract_inverted_index.early | 103, 135 |
| abstract_inverted_index.focus | 117 |
| abstract_inverted_index.life. | 35 |
| abstract_inverted_index.shift | 21 |
| abstract_inverted_index.terms | 229 |
| abstract_inverted_index.these | 243 |
| abstract_inverted_index.tools | 128 |
| abstract_inverted_index.while | 66 |
| abstract_inverted_index.‘4P | 12, 42 |
| abstract_inverted_index.access | 239 |
| abstract_inverted_index.atopic | 179 |
| abstract_inverted_index.better | 146 |
| abstract_inverted_index.burden | 158 |
| abstract_inverted_index.engage | 217 |
| abstract_inverted_index.ensure | 253 |
| abstract_inverted_index.guides | 63 |
| abstract_inverted_index.public | 123 |
| abstract_inverted_index.remain | 227 |
| abstract_inverted_index.review | 37 |
| abstract_inverted_index.safety | 28 |
| abstract_inverted_index.target | 172 |
| abstract_inverted_index.Genetic | 74 |
| abstract_inverted_index.cancer. | 161 |
| abstract_inverted_index.digital | 127 |
| abstract_inverted_index.disease | 191, 210 |
| abstract_inverted_index.earlier | 198 |
| abstract_inverted_index.enabled | 86 |
| abstract_inverted_index.engages | 139 |
| abstract_inverted_index.ethical | 235 |
| abstract_inverted_index.genetic | 67 |
| abstract_inverted_index.healthy | 206 |
| abstract_inverted_index.improve | 24, 69, 93 |
| abstract_inverted_index.leading | 144 |
| abstract_inverted_index.machine | 99 |
| abstract_inverted_index.making, | 143 |
| abstract_inverted_index.patient | 94 |
| abstract_inverted_index.prevent | 209 |
| abstract_inverted_index.quality | 33 |
| abstract_inverted_index.reduces | 156 |
| abstract_inverted_index.through | 10 |
| abstract_inverted_index.ABSTRACT | 0 |
| abstract_inverted_index.Advances | 1 |
| abstract_inverted_index.BRAF/MEK | 90 |
| abstract_inverted_index.However, | 225 |
| abstract_inverted_index.approach | 9, 152 |
| abstract_inverted_index.cancers. | 114 |
| abstract_inverted_index.concepts | 48 |
| abstract_inverted_index.decision | 142 |
| abstract_inverted_index.economic | 233 |
| abstract_inverted_index.efficacy | 26 |
| abstract_inverted_index.enabling | 102, 168, 197 |
| abstract_inverted_index.examples | 50 |
| abstract_inverted_index.explores | 38 |
| abstract_inverted_index.forecast | 190 |
| abstract_inverted_index.increase | 130 |
| abstract_inverted_index.insights | 68 |
| abstract_inverted_index.maintain | 204 |
| abstract_inverted_index.melanoma | 110 |
| abstract_inverted_index.optimize | 223 |
| abstract_inverted_index.outcomes | 154 |
| abstract_inverted_index.patients | 140, 215 |
| abstract_inverted_index.requires | 245 |
| abstract_inverted_index.research | 163 |
| abstract_inverted_index.response | 194 |
| abstract_inverted_index.targeted | 64, 87 |
| abstract_inverted_index.adherence | 147 |
| abstract_inverted_index.behaviors | 133 |
| abstract_inverted_index.campaigns | 125 |
| abstract_inverted_index.detection | 104 |
| abstract_inverted_index.education | 124 |
| abstract_inverted_index.embracing | 5 |
| abstract_inverted_index.equitable | 238 |
| abstract_inverted_index.including | 98 |
| abstract_inverted_index.learning, | 100 |
| abstract_inverted_index.melanoma, | 84 |
| abstract_inverted_index.microbial | 173 |
| abstract_inverted_index.model’: | 13 |
| abstract_inverted_index.molecular | 61 |
| abstract_inverted_index.mutations | 82 |
| abstract_inverted_index.optimizes | 153 |
| abstract_inverted_index.outcomes. | 95, 149, 224 |
| abstract_inverted_index.patient's | 32 |
| abstract_inverted_index.proactive | 8, 119 |
| abstract_inverted_index.profiling | 62 |
| abstract_inverted_index.psoriasis | 181 |
| abstract_inverted_index.research, | 249 |
| abstract_inverted_index.therapies | 88 |
| abstract_inverted_index.treatment | 25, 231 |
| abstract_inverted_index.Addressing | 242 |
| abstract_inverted_index.Microbiome | 162 |
| abstract_inverted_index.Predictive | 96, 184 |
| abstract_inverted_index.Preventive | 115, 200 |
| abstract_inverted_index.assessment | 107 |
| abstract_inverted_index.challenges | 226, 244 |
| abstract_inverted_index.conditions | 176 |
| abstract_inverted_index.detection. | 136 |
| abstract_inverted_index.encourages | 214 |
| abstract_inverted_index.imbalances | 174 |
| abstract_inverted_index.inhibitors | 91 |
| abstract_inverted_index.innovative | 246 |
| abstract_inverted_index.integrated | 151 |
| abstract_inverted_index.microbiome | 187, 207 |
| abstract_inverted_index.prediction | 71 |
| abstract_inverted_index.profiling, | 75 |
| abstract_inverted_index.protection | 132 |
| abstract_inverted_index.signatures | 188 |
| abstract_inverted_index.solutions, | 247 |
| abstract_inverted_index.strategies | 116, 201, 251 |
| abstract_inverted_index.treatment, | 196 |
| abstract_inverted_index.treatments | 170 |
| abstract_inverted_index.Predictive, | 15 |
| abstract_inverted_index.Preventive, | 16 |
| abstract_inverted_index.dermatitis, | 180 |
| abstract_inverted_index.dermatology | 3, 185, 213 |
| abstract_inverted_index.innovations | 52 |
| abstract_inverted_index.medicine’ | 43 |
| abstract_inverted_index.microbiome. | 58 |
| abstract_inverted_index.prevention. | 73 |
| abstract_inverted_index.transformed | 166 |
| abstract_inverted_index.treatments, | 65 |
| abstract_inverted_index.applications | 40 |
| abstract_inverted_index.dermatologic | 259 |
| abstract_inverted_index.dermatology, | 45, 167 |
| abstract_inverted_index.highlighting | 46 |
| abstract_inverted_index.personalized | 169 |
| abstract_inverted_index.Participatory | 18, 137, 212 |
| abstract_inverted_index.Personalized, | 14 |
| abstract_inverted_index.accessibility | 255 |
| abstract_inverted_index.collaborative | 248 |
| abstract_inverted_index.intervention. | 199 |
| abstract_inverted_index.optimization, | 232 |
| abstract_inverted_index.technologies, | 97 |
| abstract_inverted_index.considerations | 236 |
| abstract_inverted_index.exacerbations. | 211 |
| abstract_inverted_index.identification | 79 |
| abstract_inverted_index.non‐melanoma | 112 |
| abstract_inverted_index.sustainability, | 234 |
| abstract_inverted_index.onco‐dermatology | 54 |
| abstract_inverted_index.onco‐dermatology, | 60 |
| abstract_inverted_index.patient‐centered, | 7 |
| abstract_inverted_index.cost‐effectiveness | 257 |
| abstract_inverted_index.microbiome‐focused | 219 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 4 |
| institutions_distinct_count | 5 |
| citation_normalized_percentile.value | 0.88922248 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |